X-15455895-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001018109.3(PIR):c.433G>A(p.Asp145Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,209,455 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000021 ( 0 hom. 12 hem. )
Consequence
PIR
NM_001018109.3 missense
NM_001018109.3 missense
Scores
5
12
Clinical Significance
Conservation
PhyloP100: 1.52
Genes affected
PIR (HGNC:30048): (pirin) This gene encodes a member of the cupin superfamily. The encoded protein is an Fe(II)-containing nuclear protein expressed in all tissues of the body and concentrated within dot-like subnuclear structures. Interactions with nuclear factor I/CCAAT box transcription factor as well as B cell lymphoma 3-encoded oncoprotein suggest the encoded protein may act as a transcriptional cofactor and be involved in the regulation of DNA transcription and replication. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.047415763).
BS2
High Hemizygotes in GnomAdExome4 at 12 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIR | NM_001018109.3 | c.433G>A | p.Asp145Asn | missense_variant | 5/10 | ENST00000380420.10 | NP_001018119.1 | |
PIR | NM_003662.4 | c.433G>A | p.Asp145Asn | missense_variant | 5/10 | NP_003653.1 | ||
PIR-FIGF | NR_037859.2 | n.485G>A | non_coding_transcript_exon_variant | 4/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIR | ENST00000380420.10 | c.433G>A | p.Asp145Asn | missense_variant | 5/10 | 1 | NM_001018109.3 | ENSP00000369785.5 | ||
PIR | ENST00000380421.3 | c.433G>A | p.Asp145Asn | missense_variant | 5/10 | 1 | ENSP00000369786.3 | |||
PIR | ENST00000476381.5 | n.383G>A | non_coding_transcript_exon_variant | 4/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000891 AC: 1AN: 112177Hom.: 0 Cov.: 23 AF XY: 0.0000291 AC XY: 1AN XY: 34327
GnomAD3 genomes
AF:
AC:
1
AN:
112177
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34327
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000872 AC: 16AN: 183464Hom.: 0 AF XY: 0.000103 AC XY: 7AN XY: 67902
GnomAD3 exomes
AF:
AC:
16
AN:
183464
Hom.:
AF XY:
AC XY:
7
AN XY:
67902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000210 AC: 23AN: 1097278Hom.: 0 Cov.: 29 AF XY: 0.0000331 AC XY: 12AN XY: 362650
GnomAD4 exome
AF:
AC:
23
AN:
1097278
Hom.:
Cov.:
29
AF XY:
AC XY:
12
AN XY:
362650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000891 AC: 1AN: 112177Hom.: 0 Cov.: 23 AF XY: 0.0000291 AC XY: 1AN XY: 34327
GnomAD4 genome
AF:
AC:
1
AN:
112177
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34327
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
14
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.433G>A (p.D145N) alteration is located in exon 5 (coding exon 4) of the PIR gene. This alteration results from a G to A substitution at nucleotide position 433, causing the aspartic acid (D) at amino acid position 145 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Benign
T;T
Sift4G
Uncertain
T;T
Polyphen
B;B
Vest4
MutPred
Loss of ubiquitination at K144 (P = 0.0613);Loss of ubiquitination at K144 (P = 0.0613);
MVP
MPC
0.024
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at